Literature DB >> 30983021

Effect of p-coumaric acid on the erectogenic enzyme activities and non-protein thiol level in the penile tissue of normal and doxorubicin-induced oxidative stress male rat.

Sunday Idowu Oyeleye1,2, Stephen Adeniyi Adefegha1, Felix Abayomi Dada3, Bathlomew Maduka Okeke1, Ganiyu Oboh1.   

Abstract

This study investigated effect of p-coumaric acid (PCA) on erectogenic enzyme activity and non-protein thiol level in the penile tissue of normal and doxorubicin (DOX)-induced oxidative stress male rat. Sixty-four (64) adult male rats weighing between 170 and 180 g were used for this work. After 14 days of acclimatisation, the rats were divided into eight groups (n = 8). Rats were orally pre-treated with PCA dose dependently (50 and 100 mg/kg body weight [b.w.t]) and vitamin E (100 mg/kg b.w.t) for 14 days before induction with a single dose of DOX (15 mg/kg b.w.t, via i.p.). The result revealed that arginase, acetylcholinesterase (AChE), angiotensin-I-converting enzyme (ACE), phosphodiesterase-5 (PDE-5), adenosine monophosphohydrolase (AMPdase) activities were significantly (p < 0.05) higher in the DOX-induced rats as against the control, which was significantly p < 0.05) higher when compared to normal rats treated with PCA. PCA also improved non-protein thiol level in the penile tissue of both normal and DOX-induced rats. Hence, this study revealed that PCA is capable of causing inhibitory effects on the activities of enzymes, associated with oxidative stress-induced erectile dysfunction (ED) and could also be used as an aphrodisiac agent in the management/treatment of ED.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  doxorubicin; erectogenic enzymes; non-protein thiol; oxidative stress; p-coumaric acid

Mesh:

Substances:

Year:  2019        PMID: 30983021     DOI: 10.1111/and.13281

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  1 in total

1.  Synergistic antioxidant effects of natural compounds on H2O2-induced cytotoxicity of human monocytes.

Authors:  Reda Ben Mrid; Najat Bouchmaa; Wessal Ouedrhiri; Abdelhamid Ennoury; Zakia ZouaouI; Imad Kabach; Mohamed Nhiri; Rachid El Fatimy
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.